21Shares Files Amended S-1 for Spot Injective ETF on Nasdaq

21Shares filed an amended S-1 with the SEC to list a spot Injective ETF (TINJ) on Nasdaq, tracking the INJ token's price. The ETF, sponsored by 21Shares, will hold INJ through Coinbase and BitGo, with FTSE setting the benchmark. Approval from the SEC and Nasdaq is still required.

Original reporting
Published Sep 19, 2026, 2:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 19, 2026, 4:55 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
21Shares Files Amended S-1 for Spot Injective ETF on Nasdaq — source image
Decision brief

The 30-second read

Low
01

Why it matters

The amendment adds detail but does not guarantee approval; traders should monitor SEC feedback.

02

Market read

First filing for a spot INJ ETF could shape future crypto ETF approvals and affect INJ token price.

03

What to watch

Potential tax and regulatory risks from staking INJ within the trust could deter investors.

Relevance 6/10Novelty 6/10Timing: filed Sep 18, 2026

Background

21Shares is expanding its crypto ETF lineup; the Injective Network token (INJ) has seen recent institutional use.

Market effects

Adds another alt‑coin ETF candidate, increasing competition among crypto asset managers.

May influence U.S. crypto market sentiment and institutional inflows.

Highlights growing regulatory interest in spot crypto ETFs worldwide.

Counterpoint

SEC may reject the filing, limiting upside and keeping INJ illiquid for retail investors.

Key entities

  • 21Shares

    Issuer of the proposed spot INJ ETF.

  • Injective Network

    Native token INJ targeted by the ETF.

Related articles

Low

Injective Surges 3.25% on Solana Launch, Regulatory Clarity

Injective (INJ) rose 3.25% in 27 hours due to its launch on Solana, regulatory clarity from the SEC, and institutional signals. The token's integration into major Solana platforms and reduced legal risks boosted its appeal. Strong on-chain activity and a positive altcoin market also supported the price increase.

Med

Injective (INJ) Surges 10.47% Amid Multiple Catalysts

Injective (INJ) surged 10.47% in 24 hours, driven by integration with Solana, new liquidity venues, and upcoming upgrades. INJ is now tradable on Raydium and supported by Phantom wallet. Circle's USDC migration and ETF filings also contributed to the rally. INJ's volume increased 50.61%, outperforming a flat crypto market.

High

Injective (INJ) Surges 17-18% on Solana Launch and ETF Progress

Injective (INJ) surged 17-18% in 24 hours due to its native launch on Solana and progress on a US-listed ETF. The token is now live on Solana with integrations across major DeFi platforms. The ETF, targeting a Nasdaq listing under 'TINJ,' aims to stake 40-60% of its INJ holdings. Trading volume spiked 181% to $226.6 million.

High

Injective (INJ) Surges 3.87% on Solana Integration

Injective (INJ) surged 3.87% in 15 hours due to its integration with Solana, allowing trading on Solana-based platforms like Raydium. The move was driven by increased attention, trading routes, and perceived demand, with social media amplifying the news. According to reports, INJ is now live on multiple Solana DeFi and memecoin venues, expanding its user base and liquidity.

$BTC-USDLowAI 8/10

U.S. government moves seized Bitcoin to Coinbase Prime

U.S. government wallets transferred approximately $770 million in seized Bitcoin to Coinbase Prime. Separately, 12,267 BTC, linked to the Bitfinex hack, moved to new addresses. U.S. spot Ether ETFs saw $72.54 million in outflows on October 8, continuing a streak of withdrawals. Ledger requested a reseller to halt sales during an investigation of lost funds. An Ethereum whale had a large liquidation but reopened a long position.